Pharmacy school

Final Days to Register for the 2 Day Online Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World Training Course (March 7-8, 2024)

Retrieved on: 
Monday, February 12, 2024

What are the core competencies of effective leaders in the pharmaceutical industry?

Key Points: 
  • What are the core competencies of effective leaders in the pharmaceutical industry?
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World Training Course (Online Event) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024

What are the core competencies of effective leaders in the pharmaceutical industry?

Key Points: 
  • What are the core competencies of effective leaders in the pharmaceutical industry?
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

2023 CAPA (Corrective and Preventative Action) Procedures Training Course: How to Improve your Processes and Implement and Document an Effective CAPA Quality System

Retrieved on: 
Friday, October 27, 2023

Implementation - execute the action plan, eg stakeholder analysis, the transition curve

Key Points: 
  • Implementation - execute the action plan, eg stakeholder analysis, the transition curve
    Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff.
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including 'The Planning of International Drug Development', in the Clinical Research Manual, Euromed and the 'Impact of Brexit', RQA Journal 2017.

180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake

Retrieved on: 
Monday, August 7, 2023

The PK study will seek to determine how much CBD is taken up into the blood of volunteers.

Key Points: 
  • The PK study will seek to determine how much CBD is taken up into the blood of volunteers.
  • The dosage form has been shown in preliminary testing in rats to increase uptake of CBD, decrease absorption variability and enable controlled release pharmacokinetics.
  • Based on these animal results, a human PK study is being designed to test whether the formulation increases CBD blood levels after oral administration.
  • The currently available plant-based CBD formulations may contain up to 100 compounds and not just the CBD molecule.

Skincare Tech Brand AMIRO Receives QTL Certification from SGS to Strengthen R&D Efforts

Retrieved on: 
Monday, July 31, 2023

SGS, a globally recognized testing, inspection and certification organization with thousands of branches and laboratories worldwide, introduced the QTL certification for laboratory witness testing.

Key Points: 
  • SGS, a globally recognized testing, inspection and certification organization with thousands of branches and laboratories worldwide, introduced the QTL certification for laboratory witness testing.
  • As an SGS-accredited testing location, AMIRO LAB will undergo witness testing by SGS during the certification process, ensuring the accuracy and reliability of the test data.
  • From its inception, AMIRO has established its AMIRO LAB to focus on innovative applications of photonic and medical technologies in the beauty and skincare field.
  • The latest SGS' awarding of the QTL certification to AMIRO is a testament to the brand's advanced laboratory equipment and robust quality management system.

2023 CAPA (Corrective and Preventative Action) Procedures Training Course: How to Improve your Processes and Implement and Document an Effective CAPA Quality System - ResearchAndMarkets.com

Retrieved on: 
Friday, July 7, 2023

Implementation - execute the action plan, eg stakeholder analysis, the transition curve

Key Points: 
  • Implementation - execute the action plan, eg stakeholder analysis, the transition curve
    Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff.
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

BNS Ophthalmics appoints Joseph Papa and Ari Kellen to the Board of Directors

Retrieved on: 
Wednesday, June 21, 2023

ATHENS, Greece, June 21, 2023 /PRNewswire/ -- BNS Ophthalmics (BNSO) is pleased to announce the appointments of Joseph Papa and Ari Kellen to the Board of Directors.

Key Points: 
  • ATHENS, Greece, June 21, 2023 /PRNewswire/ -- BNS Ophthalmics (BNSO) is pleased to announce the appointments of Joseph Papa and Ari Kellen to the Board of Directors.
  • Joseph and Ari, having worked together, bring an impressive and successful track record of leadership and achievements.
  • The presence of Joseph and Ari in the BNSO Board reflects their confidence in BNSO scientific potential and excitement about the future prospects of BNSO.
  • Aris Mitsopoulos, Vice President of RAFARM and CEO of BNSO, stated: "We are thrilled to welcome Joseph Papa and Ari Kellen, to our esteemed Board of Directors.

Landos Biopharma Expands Board of Directors with Appointment of Alka Batycky, Ph.D.

Retrieved on: 
Tuesday, May 30, 2023

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced the appointment of Alka Batycky, Ph.D. to its Board of Directors and Audit Committee.

Key Points: 
  • NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced the appointment of Alka Batycky, Ph.D. to its Board of Directors and Audit Committee.
  • “Dr.
  • Batycky is an accomplished biopharmaceutical executive and an important addition to Landos’ Board,” said Gregory Oakes, President and CEO of Landos.
  • Prior to this, she held executive leadership positions at various biopharmaceutical companies including Ohana Biosciences, Akashi Therapeutics, Warp Drive Bio and AMAG Pharmaceuticals.

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

Retrieved on: 
Thursday, May 25, 2023

SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for idiopathic pulmonary fibrosis was published in EMBO Molecular Medicine on the 21st.

Key Points: 
  • SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for idiopathic pulmonary fibrosis was published in EMBO Molecular Medicine on the 21st.
  • EMBO Molecular Medicine is a SCIE (Science Citation Index Expanded) journal.
  • EMBO is a world-renowned journal with an impact factor 14.005, has a ranking of top 5%.
  • Therefore, Bersiporocin can bring antifibrotic effect through reduced enzymatic activity while still maintaining its critical function in homeostasis.

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

Retrieved on: 
Thursday, May 25, 2023

SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for idiopathic pulmonary fibrosis was published in EMBO Molecular Medicine on the 21st.

Key Points: 
  • SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for idiopathic pulmonary fibrosis was published in EMBO Molecular Medicine on the 21st.
  • EMBO Molecular Medicine is a SCIE (Science Citation Index Expanded) journal.
  • EMBO is a world-renowned journal with an impact factor 14.005, has a ranking of top 5%.
  • Therefore, Bersiporocin can bring antifibrotic effect through reduced enzymatic activity while still maintaining its critical function in homeostasis.